Fletcher Payne

Chief Financial Officer, GYRE THERAPEUTICS, INC.

Companies

Aptose Biosciences Inc.Chief financial officer Feb 7, 2024 to Feb 7, 2024¹
Aptose Biosciences Inc.SR VP & Chief Fin. Officer Jun 28, 2022 to Jan 23, 2023²
GYRE THERAPEUTICS, INC.Chief financial officer Aug 20, 2015 to Sep 25, 2019³

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Aptose Biosciences Inc.0 shares⁴Jun 30, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

Jun 30, 2026Returned to company 22 shares at $1.72 of Aptose Biosciences Inc.⁴
Jun 30, 2026Returned to company 222 shares at $1.72 of Aptose Biosciences Inc.⁴
Jan 19, 2023Granted 100,000 shares of Aptose Biosciences Inc.⁵
Sep 19, 2022Bought 10,000 shares at $0.68 of Aptose Biosciences Inc.⁶

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARAptose Biosciences Inc., Chief financial officer
2
SEC EDGARAptose Biosciences Inc., SR VP & Chief Fin. Officer
3
SEC EDGARGYRE THERAPEUTICS, INC., Chief financial officer
4
SEC EDGARAptose Biosciences Inc. shares after the filing of Jun 30, 2026
5
SEC EDGARForm 4 filed Jan 23, 2023
6
SEC EDGARForm 4 filed Sep 21, 2022